telbivudine (ROADMAP)
MOH-05
Approved small_molecule active
Quick answer
telbivudine (ROADMAP) for Hepatitis B, Chronic is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hepatitis B, Chronic
- Phase
- Approved
- Modality
- small_molecule
- Status
- active